Re: Antitumor activity and safety of tivozanib (AV-951) in a phase II randomized discontinuation trial in patients with renal cell carcinoma: Editorial comment

Samir S. Taneja

doi:10.1016/j.juro.2012.08.170

Re: Antitumor activity and safety of tivozanib (AV-951) in a phase II randomized discontinuation trial in patients with renal cell carcinoma: Editorial comment

Samir S. Taneja

Biomedical Engineering

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	2149-2150
Number of pages	2
Journal	Journal of Urology
Volume	188
Issue number	6
DOIs	https://doi.org/10.1016/j.juro.2012.08.170
State	Published - Dec 2012

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.juro.2012.08.170

Cite this

@article{704b69450d004e3da7cd87cfbd8179e3,

title = "Re: Antitumor activity and safety of tivozanib (AV-951) in a phase II randomized discontinuation trial in patients with renal cell carcinoma: Editorial comment",

author = "Taneja, {Samir S.}",

year = "2012",

month = dec,

doi = "10.1016/j.juro.2012.08.170",

language = "English (US)",

volume = "188",

pages = "2149--2150",

journal = "Journal of Urology",

issn = "0022-5347",

publisher = "Elsevier Inc.",

number = "6",

}

TY - JOUR

T1 - Re

T2 - Antitumor activity and safety of tivozanib (AV-951) in a phase II randomized discontinuation trial in patients with renal cell carcinoma: Editorial comment

AU - Taneja, Samir S.

PY - 2012/12

Y1 - 2012/12

UR - http://www.scopus.com/inward/record.url?scp=84869066858&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84869066858&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2012.08.170

DO - 10.1016/j.juro.2012.08.170

M3 - Comment/debate

C2 - 23141221

AN - SCOPUS:84869066858

SN - 0022-5347

VL - 188

SP - 2149

EP - 2150

JO - Journal of Urology

JF - Journal of Urology

IS - 6

ER -

Re: Antitumor activity and safety of tivozanib (AV-951) in a phase II randomized discontinuation trial in patients with renal cell carcinoma: Editorial comment

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this